E Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.29M | Sell |
9,628
-256
| -3% | -$114K | 0.2% | 71 |
|
|
2025
Q1 | $4.79M | Buy |
9,884
+3,448
| +54% | +$1.67M | 0.23% | 66 |
|
|
2024
Q4 | $2.59M | Buy |
6,436
+1,031
| +19% | +$415K | 0.13% | 95 |
|
|
2024
Q3 | $2.51M | Buy |
5,405
+115
| +2% | +$53.5K | 0.13% | 80 |
|
|
2024
Q2 | $2.48M | Buy |
5,290
+1,061
| +25% | +$497K | 0.14% | 72 |
|
|
2024
Q1 | $1.77M | Sell |
4,229
-122
| -3% | -$51K | 0.11% | 80 |
|
|
2023
Q4 | $1.77M | Sell |
4,351
-78
| -2% | -$31.7K | 0.11% | 59 |
|
|
2023
Q3 | $1.54M | Buy |
4,429
+438
| +11% | +$152K | 0.12% | 62 |
|
|
2023
Q2 | $1.4M | Sell |
3,991
-459
| -10% | -$161K | 0.11% | 60 |
|
|
2023
Q1 | $1.4M | Sell |
4,450
-180
| -4% | -$56.7K | 0.1% | 70 |
|
|
2022
Q4 | $1.34M | Sell |
4,630
-7,018
| -60% | -$2.03M | 0.11% | 71 |
|
|
2022
Q3 | $3.37M | Buy |
11,648
+6,592
| +130% | +$1.91M | 0.31% | 39 |
|
|
2022
Q2 | $1.43M | Buy |
5,056
+539
| +12% | +$152K | 0.13% | 73 |
|
|
2022
Q1 | $1.18M | Buy |
4,517
+99
| +2% | +$25.8K | 0.04% | 80 |
|
|
2021
Q4 | $970K | Sell |
4,418
-168
| -4% | -$36.9K | 0.03% | 111 |
|
|
2021
Q3 | $832K | Buy |
+4,586
| New | +$832K | 0.03% | 97 |
|
|
2021
Q1 | $895K | Buy |
+4,165
| New | +$895K | 0.07% | 94 |
|